Home › Melanoma › New York

Pag-aaral pangklinika para sa Melanoma sa New York

52 pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa mga site sa New York.

Mga Lungsod sa New York

Opisyal na teksto ng pag-aaral (English)

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Call for Information (Investigational Site 0031), New York

Nagre-recruitPhase 1/2

6 Months – 17 Years · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT02332668

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05136196

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New York Long Island LLC, Lake Success

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06270706

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

New York Oncology Hematology, Albany

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06246916

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Roswell Park Cancer Institute, Buffalo

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06150664

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Glens Falls Hospital, Glens Falls
Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
at 8 pa

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06418204

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0142, Buffalo
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07492680

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Memorial Sloan Kettering (Melanoma/NSCLC), New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06060613

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA04-0, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06953089

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

NYU Langone Health, New York

Nagre-recruitPhase 2

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05428007

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NYU Langone Health, New York
Icahn School of Medicine At Mount Sinai Prime, New York
Clinical Research Alliance, Inc, Westbury
at 1 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06330064

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06172478

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

START Cancer Research New York-Long Island, Lake Success
University of Rochester Medical Center, Rochester

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07287917

Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07890415

Intratumoral N17350 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07339176

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 107, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05914116

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT05896839

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07749586

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Memorial Sloan Kettering Hospital, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07070232

Pan-tumor MRD Study

Guthrie Lourdes Memorial Hospital (GLMH), Binghamton
New York Cancer & Blood Specialists, Shirley

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Roswell Park Cancer Institute, Buffalo
Glens Falls Hospital, Glens Falls
NYU Langone Hospital - Long Island, Mineola
at 4 pa

Nagre-recruitPhase 3

Edad 75 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07068074

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

Weill Cornell Medicine, New York

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07661966

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT04752826

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05607095

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NYU Langone, New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04913285

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06284590

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
at 1 pa

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05837767

Project: Every Child for Younger Patients With Cancer

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
at 12 pa

Nagre-recruitObservasyonal na pag-aaral

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Nagre-recruitPhase 1/2

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

NYU Langone Health, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07504796

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06425926

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05859074

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Weill Medical College of Cornell University, New York
Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1/2

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05361174

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Perlmutter Cancer Center at NYU Langone Health, New York
Memorial Sloan-Kettering Cancer Center, New York
Columbia University, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Herbert Irving Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
Northwell Health Cancer Institute, New York

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07015190

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Northwell Health, Lake Success

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06413680

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.